| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |